 ATLANTA--BUSINESS WIRE--Virios Therapeutics, Inc. Nasdaq: VIRI, a biotechnology company focused on advancing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response, announced today that Greg Duncan, Chairman and Chief Executive Officer, will present a company overview at the virtual 2021 BIO CEO Investor Conference to be held from February 16-18, 2021. The presentation will focus on the need for new approaches to treat fibromyalgia FM 